182 related articles for article (PubMed ID: 37231665)
1. Genetic, vascular and amyloid components of cerebral blood flow in a preclinical population.
Padrela BE; Lorenzini L; Collij LE; García DV; Coomans E; Ingala S; Tomassen J; Deckers Q; Shekari M; Geus EJ; van de Giessen E; Kate MT; Visser PJ; Barkhof F; Petr J; Braber AD; Mutsaerts HJ
J Cereb Blood Flow Metab; 2023 Oct; 43(10):1726-1736. PubMed ID: 37231665
[TBL] [Abstract][Full Text] [Related]
2. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
3. Cognitive dispersion is elevated in amyloid-positive older adults and associated with regional hypoperfusion.
Holmqvist SL; Thomas KR; Edmonds EC; Calcetas A; Edwards L; Bangen KJ;
J Int Neuropsychol Soc; 2023 Aug; 29(7):621-631. PubMed ID: 36093903
[TBL] [Abstract][Full Text] [Related]
4. Amyloid and tau pathology are associated with cerebral blood flow in a mixed sample of nondemented older adults with and without vascular risk factors for Alzheimer's disease.
Swinford CG; Risacher SL; Vosmeier A; Deardorff R; Chumin EJ; Dzemidzic M; Wu YC; Gao S; McDonald BC; Yoder KK; Unverzagt FW; Wang S; Farlow MR; Brosch JR; Clark DG; Apostolova LG; Sims J; Wang DJ; Saykin AJ
Neurobiol Aging; 2023 Oct; 130():103-113. PubMed ID: 37499587
[TBL] [Abstract][Full Text] [Related]
5. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects.
Chau ACM; Cheung EYW; Chan KH; Chow WS; Shea YF; Chiu PKC; Mak HKF
Neuroimage Clin; 2020; 27():102302. PubMed ID: 32521474
[TBL] [Abstract][Full Text] [Related]
6. Decoupling of Regional Cerebral Blood Flow and Brain Function Along the Alzheimer's Disease Continuum.
Li J; Zeng Q; Luo X; Li K; Liu X; Hong L; Zhang X; Zhong S; Qiu T; Liu Z; Chen Y; Huang P; Zhang M;
J Alzheimers Dis; 2023; 95(1):287-298. PubMed ID: 37483006
[TBL] [Abstract][Full Text] [Related]
7. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Yew B; Nation DA;
Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer's disease polygenic risk score.
Tomassen J; den Braber A; van der Lee SJ; Reus LM; Konijnenberg E; Carter SF; Yaqub M; van Berckel BNM; Collij LE; Boomsma DI; de Geus EJC; Scheltens P; Herholz K; Tijms BM; Visser PJ
BMC Neurol; 2022 Dec; 22(1):484. PubMed ID: 36522743
[TBL] [Abstract][Full Text] [Related]
9. Intrusion errors moderate the relationship between blood glucose and regional cerebral blood flow in cognitively unimpaired older adults.
Thomas KR; Weigand AJ; Cota IH; Edmonds EC; Wierenga CE; Bondi MW; Bangen KJ;
Brain Imaging Behav; 2022 Feb; 16(1):219-227. PubMed ID: 34415491
[TBL] [Abstract][Full Text] [Related]
10. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.
Mattsson N; Tosun D; Insel PS; Simonson A; Jack CR; Beckett LA; Donohue M; Jagust W; Schuff N; Weiner MW;
Brain; 2014 May; 137(Pt 5):1550-61. PubMed ID: 24625697
[TBL] [Abstract][Full Text] [Related]
11. Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals.
Ebenau JL; Visser D; Verfaillie SCJ; Timmers T; van Leeuwenstijn MSSA; Kate MT; Windhorst AD; Barkhof F; Scheltens P; Prins ND; Boellaard R; van der Flier WM; van Berckel BNM
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):410-422. PubMed ID: 36071221
[TBL] [Abstract][Full Text] [Related]
12. The EMIF-AD PreclinAD study: study design and baseline cohort overview.
Konijnenberg E; Carter SF; Ten Kate M; den Braber A; Tomassen J; Amadi C; Wesselman L; Nguyen HT; van de Kreeke JA; Yaqub M; Demuru M; Mulder SD; Hillebrand A; Bouwman FH; Teunissen CE; Serné EH; Moll AC; Verbraak FD; Hinz R; Pendleton N; Lammertsma AA; van Berckel BNM; Barkhof F; Boomsma DI; Scheltens P; Herholz K; Visser PJ
Alzheimers Res Ther; 2018 Aug; 10(1):75. PubMed ID: 30075734
[TBL] [Abstract][Full Text] [Related]
13. Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease.
Fazlollahi A; Calamante F; Liang X; Bourgeat P; Raniga P; Dore V; Fripp J; Ames D; Masters CL; Rowe CC; Connelly A; Villemagne VL; Salvado O;
J Magn Reson Imaging; 2020 Feb; 51(2):505-513. PubMed ID: 31145515
[TBL] [Abstract][Full Text] [Related]
14. Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.
Wierenga CE; Hays CC; Zlatar ZZ
J Alzheimers Dis; 2014; 42 Suppl 4(Suppl 4):S411-9. PubMed ID: 25159672
[TBL] [Abstract][Full Text] [Related]
15. Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures.
Promjunyakul N; Lahna D; Kaye JA; Dodge HH; Erten-Lyons D; Rooney WD; Silbert LC
Neuroimage Clin; 2015; 8():224-9. PubMed ID: 26106546
[TBL] [Abstract][Full Text] [Related]
16. Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.
Yan L; Liu CY; Wong KP; Huang SC; Mack WJ; Jann K; Coppola G; Ringman JM; Wang DJJ
Neuroimage Clin; 2018; 17():751-760. PubMed ID: 29527482
[TBL] [Abstract][Full Text] [Related]
17. Genetically identical twin-pair difference models support the amyloid cascade hypothesis.
Coomans EM; Tomassen J; Ossenkoppele R; Tijms BM; Lorenzini L; Ten Kate M; Collij LE; Heeman F; Rikken RM; van der Landen SM; den Hollander ME; Golla SSV; Yaqub M; Windhorst AD; Barkhof F; Scheltens P; de Geus EJC; Visser PJ; van Berckel BNM; den Braber A
Brain; 2023 Sep; 146(9):3735-3746. PubMed ID: 36892415
[TBL] [Abstract][Full Text] [Related]
18. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
[TBL] [Abstract][Full Text] [Related]
19. Cerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.
Bangen KJ; Clark AL; Edmonds EC; Evangelista ND; Werhane ML; Thomas KR; Locano LE; Tran M; Zlatar ZZ; Nation DA; Bondi MW; Delano-Wood L
Front Aging Neurosci; 2017; 9():181. PubMed ID: 28642699
[TBL] [Abstract][Full Text] [Related]
20. Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer disease.
McDade E; Kim A; James J; Sheu LK; Kuan DC; Minhas D; Gianaros PJ; Ikonomovic S; Lopez O; Snitz B; Price J; Becker J; Mathis C; Klunk W
Neurology; 2014 Aug; 83(8):710-7. PubMed ID: 25031286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
